Fortress Biotech, Inc.

NASDAQ:FBIO

1.54 (USD) • At close March 7, 2025
Bedrijfsnaam Fortress Biotech, Inc.
Symbool FBIO
Munteenheid USD
Prijs 1.54
Beurswaarde 42,511,546
Dividendpercentage 0%
52-weken bereik 1.36 - 2.89
Industrie Biotechnology
Sector Healthcare
CEO Dr. Lindsay Allan Rosenwald
Website https://www.fortressbiotech.com

An error occurred while fetching data.

Over Fortress Biotech, Inc.

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin

Vergelijkbare Aandelen

Equillium, Inc. logo

Equillium, Inc.

EQ

0.796 USD

Celcuity Inc. logo

Celcuity Inc.

CELC

10.64 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

TRVI

4.3 USD

Surrozen, Inc. logo

Surrozen, Inc.

SRZN

11.931 USD

Aptose Biosciences Inc. logo

Aptose Biosciences Inc.

APTO

3.17 USD

iCAD, Inc. logo

iCAD, Inc.

ICAD

2.24 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)